HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Research 2026
University of California San Francisco, United States
Title: A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
University of Saskatchewan, Canada
Catholic University of Brasilia, Brazil
UT MD Anderson Cancer Center, United States
University of Crete, Greece
Dokuz Eylul University, Turkey
Title: Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Benemérita Universidad Autónoma de Puebla, Mexico
Shanghai University, China
All India Institute of Medical Sciences, India
Title: A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Ramaiah Institute of Technology, India
Dr. Ambedkar College, India
Title: One-step salivary gelatinase activity assay: Accelerating non-invasive oral malignancy diagnosis
Jamia Hamdard University, India
Title: Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shaheed Suhrawardy Medical College and Hospital, Bangladesh
Uttara Adhunik Medical College and Hospital, Bangladesh
University of Tehran, Iran (Islamic Republic of)
Title: A systematic review of medical art therapy for cancer patients
Shiraz University of Medical Science, Iran (Islamic Republic of)
Tehran University of Medical Sciences, Iran (Islamic Republic of)
Republican Scientific Practical Medical Center of Hematology, Uzbekistan
Mengo Senior School, Uganda
Title: Beauty of herbal medicine in the global fight for cancer
Toronto Metropolitan University, Canada
Title: Oncoprofiler for Multi-Cancer Early Detection (MCED) through blood samples
Saint Louis University Sacred Heart Medical Center, Philippines
